RxSight RXST
NASDAQ RXST
$4.90 +0.13 (+2.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)

Updated

RxSight (RXST) posted Total Non-Current Liabilities of $32.93 million for Q4 2025, down 7.6% from $35.63 million a year earlier.

Analysis

RxSight (RXST) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends

Since Q4 2020, RxSight has reported Total Non-Current Liabilities for 6 quarters.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -42.6% (FY2020 to FY2025).
  • In prior years, RxSight's Total Non-Current Liabilities was $35.63 million in FY2024 and $54.48 million in FY2021 (-89.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn -
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 40.46 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 21.28 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 17.56 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 2.57 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 23.92 Bn
10 RxSight 198.36 Mn -10.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 32.93 Mn
Dec 31, 2024 35.63 Mn
Dec 31, 2021 54.48 Mn
Sep 30, 2021 52.85 Mn
Jun 30, 2021 405.67 Mn
Dec 31, 2020 526.25 Mn
API Access

RxSight Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RXST&period=max&api_key=YOUR_API_KEY